Vedanta Capital
Highly Engaged Employees
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
250 W 55th St Ste 16C, New York City, Ne...Phone Number
(212) 710-5220Website
www.vedacap.comRevenue
<$5 MillionIndustry
About Vedanta Capital
Vedanta Capital Org Chart
Is Vedanta Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Vedanta Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Vedanta Capital is spiking on competitors!
Funding: Get notified immidiatlly once Vedanta Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vedanta Capital
Check if Vedanta Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vedanta Capital launches new products
Earning: See what the market has to say on Vedanta Capital recently announced quarterly report
Click to see if Vedanta Capital had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Vedanta Capital
Find 3 more new buyers
Compare Similar Companies to Vedanta Capital
Compare insights from companies similar to Vedanta Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vedanta Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Vedanta Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Vedanta Capital.
Vedanta Capital Tech Stack
A closer look at the technologies used by Vedanta Capital
Vedanta Capital News & Media
Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.
Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHWSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Tenzing Acquisition Corp. with Reviva Pharmaceuticals, Inc. is Fair to TZAC Shareholders
New York, New York--(Newsfile Corp. - July 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who own Tenzing Acquisition Corp. ("Tenzing" or the "Company") (NASDAQ: TZAC) Common Stock.You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of TenziTenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination
NEW YORK, July 21, 2020 /PRNewswire/ -- Tenzing Acquisition Corp., a special purpose acquisition company incorporated in the British Virgin Islands ("Tenzing") (NASDAQ: TZAC), and Reviva Pharmaceuticals, Inc., a Delaware corporation ("Reviva") and a California-based clinical stage...Tenzing Acquisition Corp. Announces Extension of Deadline to Complete a Business Combination
NEW YORK, May 21, 2020 /PRNewswire/ -- Tenzing Acquisition Corp. (Nasdaq: TZACU, TZAC, TZACW) (the "Company"), a publicly-traded special purpose acquisition company, announced the vote by shareholders to extend the deadline to consummate an initial business combination from May 26, 2020...
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vedanta Capital
Vedanta Capital specializes in providing access to leading venture capital and growth equity funds for both institutions and individuals. Their offerings include funds of funds, which grant limited partners access to top-tier venture capital and growth equity funds, as well as direct funds that allow for direct investment in venture- and growth-sta... Read More